Provenance Certificate – Deep Vein Thrombosis (DVT)
Overview
| Accreditations
| Editorial methodology
| References
| Contributors
| Disclaimers
Overview
This document describes the provenance of the Whanganui district Deep Vein Thrombosis (DVT) Pathway.
This localised pathway was last updated in.
The purpose of implementing the CCP Programme in our District is to:
 Enhance accuracy of referrals
 Use best practice guidelines
 Have all information found in one place
 Enhance partnerships and collaboration across services
 Improve patient outcomes through seamless care across primary and secondary care
To cite this pathway, use the following format:
Map of Medicine – Deep Vein Thrombosis (DVT) - Whanganui View. Map of Medicine; 2015.
Editorial methodology
This care map has been based on a Map of Medicine Care Map developed according to the Map of Medicine
editorial methodology. The content of the Map of Medicine care map is based on high quality guidelines and
practice-based knowledge provided by contributors with front-line clinical experience (see contributors section of
this document). This localised version of the evidence-based, practice informed care map has been peer-reviewed
by the WDHB and WRHN Collaborative Clinical Directors and Leaders Forum and with stakeholder groups.
Consumer engagement
Development of the Whanganui Collaborative Clinical Pathways focuses on person-centred care and an
experience based co-design approach where consumers are invited to consult with the Health Promoter /
Community Developer (who sits on each pathway working group). Consumers are asked prior if possible, or if not
at the very start of the pathway process to share their experiences to assist in designing services that work for
them and their families, critiquing and feeding back on suitable consumer information and resources which can
then be incorporated into the pathways. Feedback obtained ensures we address consumer challenges and needs
within the pathway and provide suitable services, information and resources for consumers. Additional
information on patient centred care is provided by following this link and experience based co-design of health
care services at http://www.kingsfund.org.uk/projects/ebcd.
References
1
Deep Vein Thrombosis Community Pathway – Midcentral DHB, (2013)
Schutgens, R. E. G.; Haas, F. J. L.; Gerritsen, W.B. M.; Van Der Horst, F.; Nieuwenhuis, H. K.; Biesma, D. H.
2 The usefulness of five D-dimer assays in the exclusion of deep venous thrombosis._Journal of Thrombosis
and Haemostasis vol. 1 issue 5 May 2003. P. 976-981
3 New Zealand Formulary (NZF). Enoxaparin Sodium printed 24 March 2015.
4 New Zealand Formulary (NZF). Dabigatran Etexilate printed 4 May 2015.
Wells, P. S.; Forgie, M. A.; Rodger, M. A. Treatment of Venous Thromboembolism. JAMA review 19 February
5
2014.
Wilson, A. The Assessment and Management of Suspected Deep Vein Thrombosis – a clinical strategy. A
6
power point presentation July 2006.
Gupta, A., et al. Assessing 2 D-dimer age-adjustment strategies to optimize computed tomographic use in ED
7
evaluation of Pulmonary Embolism. Am J Emerg Med 32(12):1499, December 2014.
Schulman, S., et al. Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolis. N Engl J
8
Med 2009; 361:2342-2352. 10 December 2009.
Wanganui District Health Board. Wanganui District Clinical Pathway for Deep Vein Thrombosis (DVT). June
9
2013.
Landaw, S. A.; Bauer, K. A. Approach to the diagnosis and therapy of lower extremity deep vein thrombosis.
10
UpToDate online. 15 July 2014.
Contributors
The following individuals have contributed to this care map:











Louise Allsopp – Allied Health, WDHB (Facilitator)
Marcin Sosnowski – ED Consultant, WDHB
Dr Ken Young - General Practitioner
Johanita Engelbrecht – General Practitioner
Jo Mair – Registered Nurse
Diana Mallalieu – Clinical Nurse Specialist - WDHB
Lisa Sicily – Radiology, WDHB
Jon Buchan - Portfolio Manager, WDHB
Sharon Duff - Health Promotion Advisor, WRHN
Colleen Dudley - CCP Project Facilitator, WRHN (Editor)
Alaina Glue - CCP Project Facilitator, WRHN (Editor)
Other Contributors

Julie Nitschke - Clinical Director, WRHN
Disclaimers
CCP Leadership Team, Whanganui
It is not the function of the CCP Leadership Team to substitute for the role of the clinician, but to support the
clinician in enabling access to know-how and knowledge. Users of the Map of Medicine are therefore urged to
use their own professional judgement to ensure that the patient receives the best possible care. Whilst
reasonable efforts have been made to ensure the accuracy of the information on this online clinical knowledge
resource, we cannot guarantee its correctness and completeness. The information on the Map of Medicine is
subject to change and we cannot guarantee that it is up-to-date.